BOSTON and SAN DIEGO, January 18, 2022 /PRNewswire/ — Riverside Partners, LLC, a Bostonprivate equity firm, is pleased to announce the completion of an investment in the Sequoia Consulting Group, LLC (“Sequoia” or the “Company”) platform. Sequoia is a life sciences consulting group that provides technical operations, quality and scientific operations, business transformation services, and program and project management services to biotechnology, pharmaceutical, diagnostics and of medical devices. Based at San Diego, California, the company works with life science customers in all phases of the development lifecycle, from upstream R&D to commercial operations. Financial terms of the transaction, which closed in late December, were not disclosed.
“We are extremely pleased to partner with Cognac Bullen, founder and CEO of Sequoia, and her team for the company’s next chapter,” said Craig Stern, general partner at Riverside Partners. “As life science companies expand their development and manufacturing capabilities to meet growing demand for therapies and products, Sequoia is well positioned to build on its track record of success, high quality customer base and its outstanding reputation. We look forward to making additional investments and using our deep pharmaceutical services experience to support the company’s next stage of growth. »
“The Sequoia team has built an impressive company that provides unparalleled service to its customers throughout the development lifecycle,” said David Beluck, general partner at Riverside Partners. “We were attracted to Sequoia because of its talented management team and dedicated employees with deep industry expertise. Sequoia represents an attractive opportunity to invest in a growing company led by a founder with strong a tailwind in the market given its pivotal role in helping life science companies bring breakthrough treatment and product solutions to patients.
Cognac Bullen, Founder and CEO of Sequoia, added, “We are delighted to partner with Riverside Partners. Riverside brings to Sequoia a depth of pharmaceutical services experience and relationships that will help us continue to grow our service offering, grow our customer base and expand our geographic presence. Above all, the partnership with Riverside will ensure that we can continue to maintain our mission and support both our employees and our customers.”
Sequoia is a life sciences consulting group that provides technical operations, quality and scientific operations, business transformation, and program and project management to start-up companies and industry leaders in the sectors of biotechnology, pharmaceuticals, diagnostics and medical devices. Sequoia employees support all phases of development, from R&D to commercial operations. For more information, visit www.sequoiabiotech.com.
About Riverside Partners
Founded in 1989, Riverside Partners is a middle-market private equity firm with total capital commitments of $1.6 billion raised since its inception. The company focuses on growth-oriented companies in the healthcare and technology sectors. Riverside Partners is particularly experienced in partnering with founders, owners and management teams and brings deep domain expertise and operational experience to its portfolio companies. For more information, visit www.riversidepartners.com.
SOURCE Riverside Partners